Skip to content
drillr.ai
Sign up

002826.SZ

易明医药

SZSE · Healthcare · C 制造业 · CN

CNY 17.07
−1.56%
Ask drillr

  • Aug 26, 2026, 08:52 UTC

    Yiming Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 66.6797 million yuan, up 77.54% year-on-year.

    Source:

  • Aug 17, 2026, 09:51 UTC

    Yiming Pharmaceutical implemented its first share buyback on August 17, 2026, repurchasing 125,000 shares through centralized bidding for a total amount of 2.2301 million yuan.

    Source:

  • Aug 12, 2026, 12:39 UTC

    Zhou Zhan, a former shareholder holding more than 5% of Yiming Pharmaceutical, completed his share reduction plan, selling a total of 1.9 million shares through block trades on July 30 and August 11, 2026, reducing his stake to 4.6544%.

    Source:

  • Aug 7, 2026, 06:49 UTC

    Yiming Pharmaceutical established a new technology company, Shenzhen Gesipu Technology Co., Ltd., through its indirect wholly-owned subsidiary, with a business scope covering multiple artificial intelligence operations.

    Source:

  • Aug 3, 2026, 11:59 UTC

    Yiming Pharmaceutical: shareholder Zhou Zhan reduced holdings to below 5%

    Source: